Supreme Court quashes Sterling Biotech cases after ₹5,100 crore settlement
Sterling Biotech Ltd (Sandesara group) · Pharmaceuticals / gelatin
The case in brief
Visible before detection
Checks that could have surfaced it, on hindsight
Ownership / related-party links
Would have mapped dummy directors and shell entities to the promoters.
Can mislead when: Nominee directors and offshore layers hide links. Name matching throws up false positives, so every flag shows its evidence path.
End-use tracing of funds
Would have followed loans into group companies.
Can mislead when: Kubr sees only the company's own accounts. Once money reaches a third party's bank, Kubr can flag the payee but cannot see the next hop without that party's consent.
Where Kubr services would have helped
Borrower monitor
Offered in India- C3 Would have mapped dummy directors and shell entities to the promoters.
- C6 Would have followed loans into group companies.
Proceeds tracer
Offered in India- C3 Would have mapped dummy directors and shell entities to the promoters.
- C6 Would have followed loans into group companies.
Verified Snapshot
Offered in India- C3 Would have mapped dummy directors and shell entities to the promoters.
Financial diligence
Offered in India- C3 Would have mapped dummy directors and shell entities to the promoters.
Mapped from the checks each service runs. A hindsight reading of public records, not a promise that the failure would have been found.
Same pattern
A summary of public documents. It reports what the sources say. It is not Kubr's finding and not a statement of guilt.